Abstract
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy that leads to heart failure, reduced quality of life, and mortality. The vast majority of CA is caused by transthyretin (ATTR-CM) and light-chain amyloid cardiomyopathy (AL-CM).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
